Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jian Yang
Pennsylvania State University Univ Park, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
Acuitive Technologies
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Some of Dr. Yang’s technologies related to citrate based bone biomaterials have been licensed to Acuitive Technologies, Inc. To that end, Acuitive has asked Dr. Yang to serve as a consultant for the company. He works 125 hours per year, assisting the company in developing its orthopedic technologies. While this particular project does not utilize any of the licensed technologies, Dr. Yang has indicated that he and his research team our developing citrate based fluorescent materials, a part of the biomaterial family that could potentially be used by the company in the future for orthopedic applications. Given that this particular project could potentially be of interest to Acuitive, our institution determined that a management plan should be required.
Creating Safe Biodegradable Photoluminescent Implant Polymers
The success of this proposal will result in the discovering and understanding the only kind of biodegradable photoluminescent polymers (BPLPs) that intrinsically emit detectable fluorescence from the body. Based on our recent exciting development on BPLPs, we propose to further unveil the intriguing fluorescence mechanism of BPLPs and develop a methodology for custom-designing multiple classes of BPLPs to meet the versatile needs in biology and medicine. We will also demonstrate BPLP nanoparticles (biodegradable polymeric 'quantum dots') as safe in vivo imaging probes for cancer targeting and imaging. Traditional imaging agents such as organic dyes or quantum dots (QDs) are just 'imaging agents'. They cannot act as implant materials such as drug delivery vehicles or tissue engineering scaffolds. BPLPs are the only polymeric biomaterials that can serve as not only in vivo safe implant materials but also in vivo fluorescent imaging probes without incorporating traditional organic dyes or QDs thus eliminating concerns on photobleaching, low dye-conjugation ratio, and toxicity for in vivo medical applications. The success of this proposal will innovate the biodegradable implant polymers, result in new tools and methods for tracking drug delivery process and therapeutic efficacy, and monitoring structure, composition, and function of engineered tissues in real time quantitatively and non-invasively. The development of BPLPs will have huge impacts on a broad range of fields in biology and medicine including biosensing, cellular imaging, drug delivery, tissue engineering, and theranostic nanomedicine.
Filed on April 18, 2016.
Tell us what you know about Jian Yang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jian Yang filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Jian Yang | Pennsylvania State University Univ Park | Conflict of Interest | Acuitive Technologies | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.